Intuitive Surgical, Inc. $ISRG Stock Position Lowered by Turtle Creek Wealth Advisors LLC

Turtle Creek Wealth Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 28.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,926 shares of the medical equipment provider’s stock after selling 2,320 shares during the period. Turtle Creek Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $2,410,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of ISRG. WealthPlan Investment Management LLC lifted its holdings in Intuitive Surgical by 4.3% during the 3rd quarter. WealthPlan Investment Management LLC now owns 5,122 shares of the medical equipment provider’s stock worth $2,083,000 after purchasing an additional 211 shares in the last quarter. Purus Wealth Management LLC boosted its stake in Intuitive Surgical by 0.8% in the 3rd quarter. Purus Wealth Management LLC now owns 22,067 shares of the medical equipment provider’s stock worth $8,973,000 after purchasing an additional 167 shares during the period. Howard Financial Services LTD. grew its holdings in Intuitive Surgical by 23.9% during the 3rd quarter. Howard Financial Services LTD. now owns 1,120 shares of the medical equipment provider’s stock valued at $455,000 after buying an additional 216 shares in the last quarter. William Allan Corp purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $292,000. Finally, Hudock Inc. bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $207,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock traded up $6.19 during midday trading on Thursday, reaching $426.43. The company had a trading volume of 859,235 shares, compared to its average volume of 2,402,024. The firm has a 50-day moving average price of $389.39 and a 200-day moving average price of $409.80. The company has a market capitalization of $150.65 billion, a P/E ratio of 48.80, a P/E/G ratio of 3.18 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the previous year, the firm posted $1.81 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the director owned 251 shares of the company’s stock, valued at $95,129. This represents a 61.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,370 shares of company stock worth $4,891,989. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of recent analyst reports. Evercore set a $430.00 price target on shares of Intuitive Surgical in a report on Monday, July 6th. Barclays raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Wednesday, October 7th. JPMorgan Chase & Co. lowered their target price on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research note on Friday, July 17th. Robert W. Baird cut their price target on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Finally, Stifel Nicolaus reduced their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $498.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.